Together, our study uncovered the critical mechanism of B3GALT4-mediated tumor immunity, which is attraction of CD8+ T cells, and our results indicate that blockage of lipid rafts is a potential therapeutic target for NB. This evidence concerns the gene B3GALT4 and neoplasm.